title: Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
authors.affiliation: From Baker IDI Heart and Diabetes Institute, Melbourne, Australia (N.W.R.); and Department of Biochemistry and Molecular Biology, Biomedical Discovery Institute, Monash University, Clayton, Australia (S.K., A.I.S.).
authors.forename: Niwanthi W
authors.initials: NW
authors.lastname: Rajapakse
authors.affiliation: From Baker IDI Heart and Diabetes Institute, Melbourne, Australia (N.W.R.); and Department of Biochemistry and Molecular Biology, Biomedical Discovery Institute, Monash University, Clayton, Australia (S.K., A.I.S.).
authors.forename: Sanjaya
authors.initials: S
authors.lastname: Kuruppu
authors.affiliation: From Baker IDI Heart and Diabetes Institute, Melbourne, Australia (N.W.R.); and Department of Biochemistry and Molecular Biology, Biomedical Discovery Institute, Monash University, Clayton, Australia (S.K., A.I.S.).
authors.forename: A
authors.initials: A
authors.lastname: Ian Smith
mesh_terms: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D015260:Neprilysin; D011945:Receptors, Angiotensin; D013777:Tetrazoles / Q000627:therapeutic use
chemical_list: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D015260:Neprilysin